First Prophylactic Gonorrhea Vaccine Developed
by Press Release from Outbreak News Today on (#57C0N)
Intravacc, a global leader in translational research and development of viral and bacterial vaccines, has partnered with American, Buffalo, NY, based Therapyx, to further develop and optimize the world's first prophylactic vaccine against gonorrhea, NGoXIM. For this Therapyx received a $ 2.8 million Phase IIB grant in the US and has chosen to partner with Intravacc [...]
The post First Prophylactic Gonorrhea Vaccine Developed appeared first on Outbreak News Today.